CA2416546C - Probe and apparatus for measuring cerebral hemodynamics and oxygenation - Google Patents
Probe and apparatus for measuring cerebral hemodynamics and oxygenation Download PDFInfo
- Publication number
- CA2416546C CA2416546C CA002416546A CA2416546A CA2416546C CA 2416546 C CA2416546 C CA 2416546C CA 002416546 A CA002416546 A CA 002416546A CA 2416546 A CA2416546 A CA 2416546A CA 2416546 C CA2416546 C CA 2416546C
- Authority
- CA
- Canada
- Prior art keywords
- probe
- light
- optical
- cerebral
- deflection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000523 sample Substances 0.000 title claims abstract description 76
- 230000002490 cerebral effect Effects 0.000 title claims abstract description 28
- 238000006213 oxygenation reaction Methods 0.000 title claims abstract description 13
- 230000000004 hemodynamic effect Effects 0.000 title claims description 7
- 238000000576 coating method Methods 0.000 claims abstract description 24
- 239000011248 coating agent Substances 0.000 claims abstract description 23
- 210000003625 skull Anatomy 0.000 claims abstract description 18
- 210000001519 tissue Anatomy 0.000 claims abstract description 15
- 241001269524 Dura Species 0.000 claims abstract description 11
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 5
- 210000004289 cerebral ventricle Anatomy 0.000 claims abstract description 4
- 230000005540 biological transmission Effects 0.000 claims description 50
- 239000000835 fiber Substances 0.000 claims description 20
- 239000013307 optical fiber Substances 0.000 claims description 19
- 230000003287 optical effect Effects 0.000 claims description 18
- 210000005013 brain tissue Anatomy 0.000 claims description 13
- 238000011156 evaluation Methods 0.000 claims description 10
- 230000003595 spectral effect Effects 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- 229920002379 silicone rubber Polymers 0.000 claims description 2
- 239000004945 silicone rubber Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 10
- 230000003727 cerebral blood flow Effects 0.000 description 9
- 210000004556 brain Anatomy 0.000 description 8
- BDBMLMBYCXNVMC-UHFFFAOYSA-O 4-[(2e)-2-[(2e,4e,6z)-7-[1,1-dimethyl-3-(4-sulfobutyl)benzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethylbenzo[e]indol-3-yl]butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS(O)(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C BDBMLMBYCXNVMC-UHFFFAOYSA-O 0.000 description 7
- 229960004657 indocyanine green Drugs 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 4
- 108010064719 Oxyhemoglobins Proteins 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 208000029028 brain injury Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009429 electrical wiring Methods 0.000 description 3
- 238000002496 oximetry Methods 0.000 description 3
- 210000000701 subdural space Anatomy 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- 238000004497 NIR spectroscopy Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000023077 detection of light stimulus Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6864—Burr holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14553—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
- A61B5/031—Intracranial pressure
Abstract
The invention relates to a probe (1) and an apparatus for cerebral diagnosti cs and therapy, in particular for measuring absolute values of regional cerebra l flow (CBF) and cerebral oxygenation. The probe is inserted through a burr ho le in the skull and comprises illuminating means, light receiving means and a coating encapsulating said illuminating means and said light receiving means . The coating has a longitudinal shape and is adapted to fit through a burr ho le in the skull. Said coating is further adapted to slide between the skull and the dura, to be inserted into the ventricular system, and/or to be inserted into the cerebral tissue.
Description
PROBE AND APPARATUS FOR MEASURING CEREBRAL HEMODYNAMICS AND OXYGENATION
The present invention relates to a probe and an apparatus for cerebral diagnostics and therapy, in particular for measuring characteristics of cerebral hemodynamics and oxygenation, according to claim 1 respectively claim 19.
BACKGROUND OF THE INVENTION
Early detection and treatment of cerebral ischemia to prevent further neurological damage in patients with severe brain injuries belongs to the most important issues in Neurocritical Care. Further, during neurological and neurologically related surgical procedures it is often desirable to continuously monitor the oxygenation of blood which is supplied to the brain. Near infrared spectroscopy (LAIRS) is used for a wide variety of applications including invasive and non-invasive monitoring of cerebral blood flow (CBF) and cerebral oxygenation pattern, i.e.
static and dynamic characteristics of cerebral blood respectively blood flow. The LAIRS measurement of blood parameters is based upon the finding that light in the near infrared region penetrates biological tissue and is absorbed and scattered differently by hemoglobin chromophores in the ~desoxygenated respectively oxygenated state. Further, the concentration and flow of tracers such as the dye indocyaningreen (ICG) injected in the blood can be measured by NTRS to obtain information on parameters of cerebral hemodynamics, especially cerebral blood flow (CBF), mean transit time of ICG and oxygen metabolism. In pulse oximetry the temporal behaviour of LAIRS signals is CONFIRMATION COPY
evaluated to obtain information about the fraction of oxygenated hemoglobin in the arterial blood. Other parameters are the concentration of desoxygenated and oxygenated hemoglobin, the mean transit time, the cerebral blood volume (CBV), cerebral blood flow (CBF) and the tissue oxygen index (TOI). The measurement and evaluation of the aforementioned parameters with NIBS are described in Jobis, F.F., "Noninvasive infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters", Science 198; 1264-1267 and I. Roberts, P.
Fallon, et al., "Estimation of cerebral blood flow with near infrared spectroscopy and indocyaningreen", Zancet 342; 1425.
Non-invasive techniques, e.g. as described in US 4 223 680 or US 5 218 962, use NIRS optodes placed on the head. To obtain information on the chromophores oxyhemoglobin and desoxyhemoglobin in cerebral vessels the detected NIRS
signal gained by non-invasive techniques has to be corrected for effects due to light reflection and scattering by and in extracerebral tissue, i.e. skin and bone. The apparatus described in US 4 223 680 therefore comprises a reference detector which detects light reflected or scattered back to the location of the light emitting optode. The reference signal is then used to correct the measured intensity for extracerebral tissue effects. The apparatus of US 5 218 962 comprises two light emitting elements directing light through different regions of tissue and a photodetector detecting light travelling through both regions. The difference of the measured intensities represents how much the oxygen saturation of the first region differs from the second region, i.e. only relative blood parameters can be obtained. Due to the need for correction for extracerebral tissue effects non-invasive techniques are able to provide indirect information on blood parameters only.
With invasive techniques direct access to the brain and elimination of extracerebral contamination is gained through a burr hole in the skull, and a sensor which optically measures oxygenation without artifacts caused by skin and bone can then be inserted through such a burr hole. A sensor capable of monitoring several parameters instantaneously is disclosed in US 5 916 171. Several signal guides for electrical signals and a single light guide are arranged in a housing which is inserted in a burr hole having approximately the same diameter as the housing.. The light guide and the electrodes terminate vertically at the brain tissue. UV and red light is coupled into the single light guide to measure relative changes of the blood flow velocities by analyzing the signal reflected back into the same light guide using Laser Doppler flowmetry. G~lith this arrangement only relative parameters of flowing blood can be analyzed as the signal coming from static tissue components are not detectable in Laser Doppler flowmetry. Furthermore by Laser Doppler flowmetry only values of very small areas (about 1 mm2) are obtained. Futher, the probe is merely inserted into the burr hole and stabilized by the skull bone which can lead to brain injuries or artifacts in the measurements when the patient moves. It is therefore not suited for a long-term measurement. Monitoring regions of tissue other than those of the burr hole is not possible.
As the probe comprises a complex arrangement of a plurality of sensors its manufacturing costs are high and it is therefore not suited as a throw away article.
Products that contact the brain, however, should be throw away articles as sterilizing is often not sufficient to exclude a potential infection risk.
A sensor for measuring cerebral oxygen availability epidurally, i.e. between dura and skull bone, by optical reflectance is disclosed in US 5 024 226, A pair of light emitting diodes (ZED) and a photodetector are encapsulated by a coating and connected electrically to a power supply respectively a signal analyzer by a flexible wiring. The sensor tip including the diodes and the photodetector is inserted through a burr hole in the skull and maneuvered between dura and skull bone to a region chosen for the measurement.
It is therefore an object of the present invention to provide a probe and an apparatus for measuring absolute l5 values of regional cerebral flow and cerebral oxygenation through a burr hole in the skull by optical reflectance which can be manufactured at relatively low cost and is therefore suited as a throw away article.
SUMMARY OF THE INVENTION
The above and other objects of the present invention are achieved by a probe as specified in claim 1 and an apparatus as specified in claim 19. Preferred embodiments are described in the dependent claims, the description and the drawings.
The inventive probe may be used for any invasive method for cerebral diagnostics and therapy. It may be used as a probe for subdural measurements, as a ventricular probe or as a intraparencymatic probe. The coating is therefore adapted to slide between the skull and the dura, and/or to being inserted into the ventricular system, and/or to being inserted into the cerebral tissue.
The illuminating means may be active, i.e. may comprise light emitting means such as a diode and/or a laser, or passive, i.e. transmit light from an external light source to the location of measurement. If the illuminating means emit light actively, they are powered electrically. The light receiving means may be active or passive, too. In the active case they detect light in the location of measurement and generate an electric signal which is transmitted to an evaluating means. In the passive case, the receiving means are suited to receive light from the location of measurement and to transmit it to an external detector.
An especially preferred embodiment of the inventive probe has the features of claim 6 and an especially preferred embodiment of the inventive apparatus has the features of claim 20. This probe uses passive illuminating and receiving means and avoids electric components within the probe. The use of light emitting diodes for in situ generation of light, as for example in US 5 024 226, has several problematic aspects. The emission spectrum of a LED is fixed, thus a given probe cannot be adapted for monitoring different parameters with their specific wavelengths. For monitoring a given number of different parameters the same number of LEDs has to be provided within the probe, requiring a certain space, thus increasing the probe dimensions. A LED emits a broad spectrum of wavelengths, thus no sharp working wavelengths can be employed. The LEDs have to be powered electrically, i.e. an electrical wiring has to be guided in the skull.
An improper insulation of the wiring can cause electrical shortcuts which may result in brain damage. Further, the signals transferred to the analyzer are influenced by other electrical equipment, leading to wrong results. The emission characteristics of the ZED and the detection efficiency of the photodetector are affected by changes of the temperature, but drift compensation or temperature stabilization in situ is not possible. These problems are avoided by said preferred embodiment of the inventive probe. Especially, electrical signaling in the skull region is avoided. Further, the probe can easily be adapted to different wavelengths. A further advantage is that the probe can be manufactured at low cost due to the absence of electronic equipment within the probe.
The preferred inventive probe uses at least two optical transmission means each comprising one or more optical fibers, the transmission means preferably being a fiber bundle. The first transmission means transmit .light preferably in the near infrared spectral range from their proximal end to their distal end, i.e. from a light source to the patient's head. The second transmission means transmit light from their distal end to their proximal end, i.e. from the patient's head to a detection unit. The transmission means are preferably arranged substantially parallel to each other. They are encapsulated by a coating that forms an elongated flat structure. The distal termination of each.of the optical transmission means is connected to deflection means encapsulated by the same coating for deflection of light transmitted by the transmission means from the direction of transmission, preferably by an angle of 60 to 120°. Preferably the Might is deflected by approximately 90° with respect to the direction of transmission, directing light from a propagation direction parallel to the dura vertically into the brain tissue. The distance of the deflection means, acting with the respective transmission means as emitting and receiving optodes, determines the probing depth, i.e.
the depth up to which photons penetrate the tissue and are scattered back, thus the depth of the tissue region monitored. As optical fibers are small in diameter and deflection means can be manufactured small in size, e.g.
by a mirror, preferably a prism with a few millimeters edge length connected to the fiber endings or by fiber endings being inclined, a probe with a width of preferably less than about 20 mm and a thickness less than about 5 mm for a minimal invasive measurement is provided. The coating, preferably a silicone rubber or polyurethane material, fixes the spatial arrangement of transmission and deflection.means and enables by a certain stiffness at least in its axial direction maneuvering of the probe within the head. The coating also seals the components from moisture and other environmental factors. Further, the coating smoothly rounds the edges and corners of the probe which prevents injury of the brain when sliding between dura and brain tissue or dura and bone. The coating is at least in the region of the entrance respectively exit of the deflection means optically transmissive to light at the wavelengths used.
For use, the proximal termination of the first transmission means is connected to a light source emitting at one or more wavelengths, and light is directed through the first transmission and deflection means into the brain tissue where it is reflected and/or scattered by tissue components. As the optical fibers are generally able to transmit in a broad spectral range, the same fibers can be used for illumination with different wavelengths in the infrared range associated with specific chromophores in g _ the blood, e.g. oxyhemoglobin, desoxyhemoglobin, ICG.
Preferably a glass or quartz fiber having a diameter of about 50 to 100 ~,m. is used. Preferably the transmission respectively comprise a bundle of 300 to 600 fibers each.
For example, a wavelength of 782 nm is used to monitor the ICG concentration while oxygenation of hemoglobin is monitored at 908 and/or 857 nm.
When in use, the proximal termination of the second transmission means is connected to a photodetector whose output signal is analyzed by a evaluation means, e.g. a computer. Light reflected and/or scattered by brain tissue is directed into the second transmission means by the second deflection means picking up light coming from a direction approximately normal to the direction of transmission within the fiber. First and second deflection means are directed towards the same direction approximately. The photodetector being outside the body has the advantage that it can be stabilized against temperature drift. Further, as it is part of the permanent analyzing system and does not have to be a low cost product, detectors with high detection efficiency, e.g.
photomultipliers or avalanche diodes can be used. Thus the intensity of emitted light can be reduced maintaining a desired signal to noise ratio. For example, it is illuminated at a 1 kHz repetition rate, 50 ns pulse duration and a mean laser power of 1 mW.
The optical probe can be combined with a pressure sensor for intracranial pressure measurement and signal transfer means connected to it for transmitting signals containing pressure information to a pressure signal analyzer.
Thereby the following parameters can be monitored simultaneously by inserting one probe in the subdural space through a single burr hole in the skull:
oxyhemoglobin, desoxyhemoglobin, means cerebral arterial oxygen saturation SaO~~erebrali mean transit time of ICG
mttICG, cerebral blood flow CBF and cerebral blood volume CBV.
The inventive apparatus comprises an inventive probe, light emitting means, light detecting means and evaluation means. For example, a standard NIRS system used for non-invasive oximetry can be combined with the inventive probe. The light emitting means, preferably one or more diode lasers or a tunable laser, e.g. a dye laser, are coupled with the proximal end of the first transmission means, such that emitted light at one or more wavelengths is transmitted to the brain tissue. With an assembly of beamsplitters or bandpass filters light from different light sources can be coupled into common fibers of the first transmission means. The working wavelengths respectively light sources are changed dependent on which wavelength is needed for the measurement of the chromophores in the blood. Alternatively, for each of the preferably three wavelengths a separate fiber bundle can be prodded having the advantage of easier alteration of the working wavelength and the disadvantage of increase of the number of fibers needed for a given illumination intensity leading to an increase in width or thickness of the probe.
The light detecting means, preferably a photomultiplier, are coupled with the proximal end of the second transmission means. Bandpass or other optical filters for the suppression of undesired signal components can be arranged in the transmission path.
The evaluation means for the evaluation of the detected signals preferably comprise a computer with evaluation routines.
BRIEF DESCRIPTION OF THE DRAWINGS
Some of the objects and advantages of the present invention have been stated, others will appear when the following description is considered together with the drawings in which Fig. 1 shows a plan view of an inventive probe;
Fig. 2 shows a side view of the inventive probe of fig.
1;
Fig. 3 shows the transmission paths of an inventive probe;
Fig. 4 shows an inventive apparatus;
Fig. 5 shows a plan view of an inventive probe inte-grated in a ventricular catheter;
Fig. 6 shows an axial cross section of the probe of fig. 5;
Fig. 7A,B show an inventive probe with an additional pres-sure sensor;
Fig. 8 shows a saggital view of an inventive probe in-serted in the subdural space;
Fig. 9 shows a coronar view of an inventive probe in-serted in the subdural space;
Fig. 10 shows a plan view and a side view of another in-ventive probe.
Fig. 1 and 2 show a probe 1 comprising a bundle of first optical fibers 4 as first transmission means 2 and a bundle of second optical fibers 5 as second transmission means 3. The fibers 4, 5 are aligned substantially parallel to each other. The distal end 15 of the first transmission means 2 is coupled to first deflection means 6, a prism 8, by the first optical fibers 4 being connected to one face of the prism 8. Thereby an incoming light beam 30 is deflected from a direction A
corresponding to the direction of the first or second fibers 4, 5 into a direction B approximately normal to the plane 53 defined by the first and second transmission means 2, 3 respectively fibers 4, 5. In the same way the distal end 16 of the second transmission means 3 is coupled to second deflection means 7, a prism 9, by the second optical fibers 5 being connected to one face of the prism 9. Thereby light 31 coming from the outside from a direction B is deflected into the direction A and into the second fibers 5. The face of the prisms 8, 9 oriented at 45° with respect to the fibers 4, 5 acts as a mirror 10, 11, whose reflectance may be enhanced by a reflecting coating. The distance D1 of the first and second deflection means 8, 9 is fixed and amounts to 35 mm, generally 10 to 50 mm. The aforementioned components are encapsulated by a soft coating 12 which forms a body with round corners having a width W of approximately 7 mm, generally less than 20 mm, and a thickness T of 2 mm, generally less than about 5 mm. This body enables sliding of the probe 1 between dura and brain tissue without damaging or compressing the brain, as shown in fig. 8 and 9. The coating has optical windows 13, 14 in the region of the exits of the deflection means 6, 7 transmitting the emitted and reflected photons.
Fig. 3 shows the transmission paths of an inventive probe, e.g. that of fig. 1 and 2. The proximal end 21 of the first transmission means 2, comprising a bundle of optical fibers 4 of about 1,5 mm2 sectional area, is split in three sub-paths of about 0,5 mm~ sectional area that are terminated by plugs 18, 19, 20 for coupling with external light sources of three different wavelengths (not shown).
The proximal end 22 of the second transmission means 3, comprising a bundle of optical fibers 5 of about 1,5 mm2 sectional area, terminates in a plug 23 for coupling with a photodetector. The first and second transmission means are guided in a common cable of 1 to 2 m length L2. The probe 1 as such, i.e. the part adapted to be introduced into the patient's skull, has a length L1 of about 20 to 30 cm. The distal ends 15, 1~ of the first and second transmission means 2, 3 are coupled with deflection means 6, 7 having a distance D1 of 35 mm as described above.
Fig. 4 shows an inventive apparatus comprising an inventive probe 1, e.g. as shown in fig. 1 and 2, an NTRS
respectively oximetry system 26 and a computer 29 as controlling and evaluating unit 27, 28. Via the first transmission means 2 the probe is connected to the exit of the light source 24 of the system 26. The emission of light (wavelength, pulse width and repetition frequency, power) is controlled by the controlling unit 27. The scattered light is guided by the second transmission means 3 to the photodetector 25, whose output signal is evaluated by the evaluating unit 28.
Fig. 5 and 6 show an inventive probe 32 integrated in a ventricular catheter in a plan view respectively an axial cross section. The catheter comprises a flexible tube 33 defining a channel 36 with 1 to 2 mm diameter and having openings 34 in the tube walls through which access to brain tissue is gained via the channel 36. First and second transmission 37, 38 and deflection means 39, 40 are integrated in the tube walls proximate to the openings at about 15 to 30 mm distance to the catheter tip. The distance D2 of first and second deflection means 39, 40 is about 15 mm resulting in a probing depth of approximately mm. As the tube walls are less than 1 mm thick, preferably about 0,5 mm, the deflection means 39, 40 are realized by cutting the terminating faces of the optical 15 fibers 41 constituting the transmission means 37, 38 with an inclination of approximately 45° with respect to the fiber direction. The inclined face 42 serves as a mirror to deflect light with about 90° from or into the fiber.
V~lith this probe 32 monitoring of parameters by NIRS
techniques can be combined with analytical or therapeutic techniques, for example cerebrospinal fluid analysis and drainage, requiring direct access to deeper brain areas, especially in ventricles.
Fig. 7A, B show an inventive probe 1 with an additional pressure sensor 43. The probe 1 with first and second transmission means 2, 3 and deflection means 6, 7 encapsulated by a soft coating 12 has been described before. A pressure sensor 43 having a signal guide 44 encapsulated by coating 12' is attached to or made in a single piece with the probe 1. For example, as shown in fig. 7A, a standard pressure probe can be equipped with an inventive probe, whereby the respective coatings 12, 12' are attached to each other without forming sharp edges.
Alternatively, as shown in fig. 7B, the pressure sensor is an integral part of the inventive probe, encapsulated by a common coating 12, 12'. The probe thus enables simultaneous monitoring of cerebral hemodynamics and oxygenation as well as pressure through a single probe and a single burr hole in the scull.
Fig. 8 and 9 show different views of an inventive subdural probe 1 with optical probing and a pressure sensor 43 as shown in Fig. 7 inserted through a burr hole 47 in the skull bone 46 between dura 48 and brain tissue 49. As shown, the probe is first guided through a cut 54 in the skin 45, then through the burr hole 47 spaced from the cut 54, thereby minimizing the infection risk by preventing direct contact of brain tissue with the ambient air during long-term monitoring. Zight 30 is deflected by the first deflection means 6 into the brain tissue 49, traveling substantially normal to dura 48 or brain surface where it is absorbed, reflected or scattered. Due to reflection and scattering a part 31 of the light is deviated to the second deflection means 7 and coupled into the second transmission means. The area 55 reached by light emitted by the emitting optode and received by the receiving optode having a distance D is sketched in dashed lines.
The penetration or probing depth P is the maximum depth from where photons are received. V~Tith a distance D of 35 mm the white brain matter can be investigated. The proximal ends 21, 22 of the optical transmission means and of the pressure signal guide terminate in different plugs 50, 51 to be connected with oximetry respectively pressure monitoring systems (not shown).
Fig. 10 shows in its upper part a plan view' and in its lower part a side respectively sectional view of another inventive probe 101 with active generation and detection of light. Light emitting means 102, preferably a diode laser, and light detecting means 106, preferably a receiver diode, are encapsulated by a coating 103, which is preferably made of silicone. The light emitting means 102 are connected via an electrical wiring 104 to an external power supply and/or control unit. The light detecting means 106 are connected via an electrical wiring 105 to an external evaluation system for evaluation of the signals generated by the detecting means 106. The probe 101 is adapted to subdural measurements and has a total length L of about 250 mm, a width W of about 7 mm, and a height T of about 2 mm. The distance D1 between the light emitting and detecting means 102, 106 is about 35 mm.
The present invention relates to a probe and an apparatus for cerebral diagnostics and therapy, in particular for measuring characteristics of cerebral hemodynamics and oxygenation, according to claim 1 respectively claim 19.
BACKGROUND OF THE INVENTION
Early detection and treatment of cerebral ischemia to prevent further neurological damage in patients with severe brain injuries belongs to the most important issues in Neurocritical Care. Further, during neurological and neurologically related surgical procedures it is often desirable to continuously monitor the oxygenation of blood which is supplied to the brain. Near infrared spectroscopy (LAIRS) is used for a wide variety of applications including invasive and non-invasive monitoring of cerebral blood flow (CBF) and cerebral oxygenation pattern, i.e.
static and dynamic characteristics of cerebral blood respectively blood flow. The LAIRS measurement of blood parameters is based upon the finding that light in the near infrared region penetrates biological tissue and is absorbed and scattered differently by hemoglobin chromophores in the ~desoxygenated respectively oxygenated state. Further, the concentration and flow of tracers such as the dye indocyaningreen (ICG) injected in the blood can be measured by NTRS to obtain information on parameters of cerebral hemodynamics, especially cerebral blood flow (CBF), mean transit time of ICG and oxygen metabolism. In pulse oximetry the temporal behaviour of LAIRS signals is CONFIRMATION COPY
evaluated to obtain information about the fraction of oxygenated hemoglobin in the arterial blood. Other parameters are the concentration of desoxygenated and oxygenated hemoglobin, the mean transit time, the cerebral blood volume (CBV), cerebral blood flow (CBF) and the tissue oxygen index (TOI). The measurement and evaluation of the aforementioned parameters with NIBS are described in Jobis, F.F., "Noninvasive infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters", Science 198; 1264-1267 and I. Roberts, P.
Fallon, et al., "Estimation of cerebral blood flow with near infrared spectroscopy and indocyaningreen", Zancet 342; 1425.
Non-invasive techniques, e.g. as described in US 4 223 680 or US 5 218 962, use NIRS optodes placed on the head. To obtain information on the chromophores oxyhemoglobin and desoxyhemoglobin in cerebral vessels the detected NIRS
signal gained by non-invasive techniques has to be corrected for effects due to light reflection and scattering by and in extracerebral tissue, i.e. skin and bone. The apparatus described in US 4 223 680 therefore comprises a reference detector which detects light reflected or scattered back to the location of the light emitting optode. The reference signal is then used to correct the measured intensity for extracerebral tissue effects. The apparatus of US 5 218 962 comprises two light emitting elements directing light through different regions of tissue and a photodetector detecting light travelling through both regions. The difference of the measured intensities represents how much the oxygen saturation of the first region differs from the second region, i.e. only relative blood parameters can be obtained. Due to the need for correction for extracerebral tissue effects non-invasive techniques are able to provide indirect information on blood parameters only.
With invasive techniques direct access to the brain and elimination of extracerebral contamination is gained through a burr hole in the skull, and a sensor which optically measures oxygenation without artifacts caused by skin and bone can then be inserted through such a burr hole. A sensor capable of monitoring several parameters instantaneously is disclosed in US 5 916 171. Several signal guides for electrical signals and a single light guide are arranged in a housing which is inserted in a burr hole having approximately the same diameter as the housing.. The light guide and the electrodes terminate vertically at the brain tissue. UV and red light is coupled into the single light guide to measure relative changes of the blood flow velocities by analyzing the signal reflected back into the same light guide using Laser Doppler flowmetry. G~lith this arrangement only relative parameters of flowing blood can be analyzed as the signal coming from static tissue components are not detectable in Laser Doppler flowmetry. Furthermore by Laser Doppler flowmetry only values of very small areas (about 1 mm2) are obtained. Futher, the probe is merely inserted into the burr hole and stabilized by the skull bone which can lead to brain injuries or artifacts in the measurements when the patient moves. It is therefore not suited for a long-term measurement. Monitoring regions of tissue other than those of the burr hole is not possible.
As the probe comprises a complex arrangement of a plurality of sensors its manufacturing costs are high and it is therefore not suited as a throw away article.
Products that contact the brain, however, should be throw away articles as sterilizing is often not sufficient to exclude a potential infection risk.
A sensor for measuring cerebral oxygen availability epidurally, i.e. between dura and skull bone, by optical reflectance is disclosed in US 5 024 226, A pair of light emitting diodes (ZED) and a photodetector are encapsulated by a coating and connected electrically to a power supply respectively a signal analyzer by a flexible wiring. The sensor tip including the diodes and the photodetector is inserted through a burr hole in the skull and maneuvered between dura and skull bone to a region chosen for the measurement.
It is therefore an object of the present invention to provide a probe and an apparatus for measuring absolute l5 values of regional cerebral flow and cerebral oxygenation through a burr hole in the skull by optical reflectance which can be manufactured at relatively low cost and is therefore suited as a throw away article.
SUMMARY OF THE INVENTION
The above and other objects of the present invention are achieved by a probe as specified in claim 1 and an apparatus as specified in claim 19. Preferred embodiments are described in the dependent claims, the description and the drawings.
The inventive probe may be used for any invasive method for cerebral diagnostics and therapy. It may be used as a probe for subdural measurements, as a ventricular probe or as a intraparencymatic probe. The coating is therefore adapted to slide between the skull and the dura, and/or to being inserted into the ventricular system, and/or to being inserted into the cerebral tissue.
The illuminating means may be active, i.e. may comprise light emitting means such as a diode and/or a laser, or passive, i.e. transmit light from an external light source to the location of measurement. If the illuminating means emit light actively, they are powered electrically. The light receiving means may be active or passive, too. In the active case they detect light in the location of measurement and generate an electric signal which is transmitted to an evaluating means. In the passive case, the receiving means are suited to receive light from the location of measurement and to transmit it to an external detector.
An especially preferred embodiment of the inventive probe has the features of claim 6 and an especially preferred embodiment of the inventive apparatus has the features of claim 20. This probe uses passive illuminating and receiving means and avoids electric components within the probe. The use of light emitting diodes for in situ generation of light, as for example in US 5 024 226, has several problematic aspects. The emission spectrum of a LED is fixed, thus a given probe cannot be adapted for monitoring different parameters with their specific wavelengths. For monitoring a given number of different parameters the same number of LEDs has to be provided within the probe, requiring a certain space, thus increasing the probe dimensions. A LED emits a broad spectrum of wavelengths, thus no sharp working wavelengths can be employed. The LEDs have to be powered electrically, i.e. an electrical wiring has to be guided in the skull.
An improper insulation of the wiring can cause electrical shortcuts which may result in brain damage. Further, the signals transferred to the analyzer are influenced by other electrical equipment, leading to wrong results. The emission characteristics of the ZED and the detection efficiency of the photodetector are affected by changes of the temperature, but drift compensation or temperature stabilization in situ is not possible. These problems are avoided by said preferred embodiment of the inventive probe. Especially, electrical signaling in the skull region is avoided. Further, the probe can easily be adapted to different wavelengths. A further advantage is that the probe can be manufactured at low cost due to the absence of electronic equipment within the probe.
The preferred inventive probe uses at least two optical transmission means each comprising one or more optical fibers, the transmission means preferably being a fiber bundle. The first transmission means transmit .light preferably in the near infrared spectral range from their proximal end to their distal end, i.e. from a light source to the patient's head. The second transmission means transmit light from their distal end to their proximal end, i.e. from the patient's head to a detection unit. The transmission means are preferably arranged substantially parallel to each other. They are encapsulated by a coating that forms an elongated flat structure. The distal termination of each.of the optical transmission means is connected to deflection means encapsulated by the same coating for deflection of light transmitted by the transmission means from the direction of transmission, preferably by an angle of 60 to 120°. Preferably the Might is deflected by approximately 90° with respect to the direction of transmission, directing light from a propagation direction parallel to the dura vertically into the brain tissue. The distance of the deflection means, acting with the respective transmission means as emitting and receiving optodes, determines the probing depth, i.e.
the depth up to which photons penetrate the tissue and are scattered back, thus the depth of the tissue region monitored. As optical fibers are small in diameter and deflection means can be manufactured small in size, e.g.
by a mirror, preferably a prism with a few millimeters edge length connected to the fiber endings or by fiber endings being inclined, a probe with a width of preferably less than about 20 mm and a thickness less than about 5 mm for a minimal invasive measurement is provided. The coating, preferably a silicone rubber or polyurethane material, fixes the spatial arrangement of transmission and deflection.means and enables by a certain stiffness at least in its axial direction maneuvering of the probe within the head. The coating also seals the components from moisture and other environmental factors. Further, the coating smoothly rounds the edges and corners of the probe which prevents injury of the brain when sliding between dura and brain tissue or dura and bone. The coating is at least in the region of the entrance respectively exit of the deflection means optically transmissive to light at the wavelengths used.
For use, the proximal termination of the first transmission means is connected to a light source emitting at one or more wavelengths, and light is directed through the first transmission and deflection means into the brain tissue where it is reflected and/or scattered by tissue components. As the optical fibers are generally able to transmit in a broad spectral range, the same fibers can be used for illumination with different wavelengths in the infrared range associated with specific chromophores in g _ the blood, e.g. oxyhemoglobin, desoxyhemoglobin, ICG.
Preferably a glass or quartz fiber having a diameter of about 50 to 100 ~,m. is used. Preferably the transmission respectively comprise a bundle of 300 to 600 fibers each.
For example, a wavelength of 782 nm is used to monitor the ICG concentration while oxygenation of hemoglobin is monitored at 908 and/or 857 nm.
When in use, the proximal termination of the second transmission means is connected to a photodetector whose output signal is analyzed by a evaluation means, e.g. a computer. Light reflected and/or scattered by brain tissue is directed into the second transmission means by the second deflection means picking up light coming from a direction approximately normal to the direction of transmission within the fiber. First and second deflection means are directed towards the same direction approximately. The photodetector being outside the body has the advantage that it can be stabilized against temperature drift. Further, as it is part of the permanent analyzing system and does not have to be a low cost product, detectors with high detection efficiency, e.g.
photomultipliers or avalanche diodes can be used. Thus the intensity of emitted light can be reduced maintaining a desired signal to noise ratio. For example, it is illuminated at a 1 kHz repetition rate, 50 ns pulse duration and a mean laser power of 1 mW.
The optical probe can be combined with a pressure sensor for intracranial pressure measurement and signal transfer means connected to it for transmitting signals containing pressure information to a pressure signal analyzer.
Thereby the following parameters can be monitored simultaneously by inserting one probe in the subdural space through a single burr hole in the skull:
oxyhemoglobin, desoxyhemoglobin, means cerebral arterial oxygen saturation SaO~~erebrali mean transit time of ICG
mttICG, cerebral blood flow CBF and cerebral blood volume CBV.
The inventive apparatus comprises an inventive probe, light emitting means, light detecting means and evaluation means. For example, a standard NIRS system used for non-invasive oximetry can be combined with the inventive probe. The light emitting means, preferably one or more diode lasers or a tunable laser, e.g. a dye laser, are coupled with the proximal end of the first transmission means, such that emitted light at one or more wavelengths is transmitted to the brain tissue. With an assembly of beamsplitters or bandpass filters light from different light sources can be coupled into common fibers of the first transmission means. The working wavelengths respectively light sources are changed dependent on which wavelength is needed for the measurement of the chromophores in the blood. Alternatively, for each of the preferably three wavelengths a separate fiber bundle can be prodded having the advantage of easier alteration of the working wavelength and the disadvantage of increase of the number of fibers needed for a given illumination intensity leading to an increase in width or thickness of the probe.
The light detecting means, preferably a photomultiplier, are coupled with the proximal end of the second transmission means. Bandpass or other optical filters for the suppression of undesired signal components can be arranged in the transmission path.
The evaluation means for the evaluation of the detected signals preferably comprise a computer with evaluation routines.
BRIEF DESCRIPTION OF THE DRAWINGS
Some of the objects and advantages of the present invention have been stated, others will appear when the following description is considered together with the drawings in which Fig. 1 shows a plan view of an inventive probe;
Fig. 2 shows a side view of the inventive probe of fig.
1;
Fig. 3 shows the transmission paths of an inventive probe;
Fig. 4 shows an inventive apparatus;
Fig. 5 shows a plan view of an inventive probe inte-grated in a ventricular catheter;
Fig. 6 shows an axial cross section of the probe of fig. 5;
Fig. 7A,B show an inventive probe with an additional pres-sure sensor;
Fig. 8 shows a saggital view of an inventive probe in-serted in the subdural space;
Fig. 9 shows a coronar view of an inventive probe in-serted in the subdural space;
Fig. 10 shows a plan view and a side view of another in-ventive probe.
Fig. 1 and 2 show a probe 1 comprising a bundle of first optical fibers 4 as first transmission means 2 and a bundle of second optical fibers 5 as second transmission means 3. The fibers 4, 5 are aligned substantially parallel to each other. The distal end 15 of the first transmission means 2 is coupled to first deflection means 6, a prism 8, by the first optical fibers 4 being connected to one face of the prism 8. Thereby an incoming light beam 30 is deflected from a direction A
corresponding to the direction of the first or second fibers 4, 5 into a direction B approximately normal to the plane 53 defined by the first and second transmission means 2, 3 respectively fibers 4, 5. In the same way the distal end 16 of the second transmission means 3 is coupled to second deflection means 7, a prism 9, by the second optical fibers 5 being connected to one face of the prism 9. Thereby light 31 coming from the outside from a direction B is deflected into the direction A and into the second fibers 5. The face of the prisms 8, 9 oriented at 45° with respect to the fibers 4, 5 acts as a mirror 10, 11, whose reflectance may be enhanced by a reflecting coating. The distance D1 of the first and second deflection means 8, 9 is fixed and amounts to 35 mm, generally 10 to 50 mm. The aforementioned components are encapsulated by a soft coating 12 which forms a body with round corners having a width W of approximately 7 mm, generally less than 20 mm, and a thickness T of 2 mm, generally less than about 5 mm. This body enables sliding of the probe 1 between dura and brain tissue without damaging or compressing the brain, as shown in fig. 8 and 9. The coating has optical windows 13, 14 in the region of the exits of the deflection means 6, 7 transmitting the emitted and reflected photons.
Fig. 3 shows the transmission paths of an inventive probe, e.g. that of fig. 1 and 2. The proximal end 21 of the first transmission means 2, comprising a bundle of optical fibers 4 of about 1,5 mm2 sectional area, is split in three sub-paths of about 0,5 mm~ sectional area that are terminated by plugs 18, 19, 20 for coupling with external light sources of three different wavelengths (not shown).
The proximal end 22 of the second transmission means 3, comprising a bundle of optical fibers 5 of about 1,5 mm2 sectional area, terminates in a plug 23 for coupling with a photodetector. The first and second transmission means are guided in a common cable of 1 to 2 m length L2. The probe 1 as such, i.e. the part adapted to be introduced into the patient's skull, has a length L1 of about 20 to 30 cm. The distal ends 15, 1~ of the first and second transmission means 2, 3 are coupled with deflection means 6, 7 having a distance D1 of 35 mm as described above.
Fig. 4 shows an inventive apparatus comprising an inventive probe 1, e.g. as shown in fig. 1 and 2, an NTRS
respectively oximetry system 26 and a computer 29 as controlling and evaluating unit 27, 28. Via the first transmission means 2 the probe is connected to the exit of the light source 24 of the system 26. The emission of light (wavelength, pulse width and repetition frequency, power) is controlled by the controlling unit 27. The scattered light is guided by the second transmission means 3 to the photodetector 25, whose output signal is evaluated by the evaluating unit 28.
Fig. 5 and 6 show an inventive probe 32 integrated in a ventricular catheter in a plan view respectively an axial cross section. The catheter comprises a flexible tube 33 defining a channel 36 with 1 to 2 mm diameter and having openings 34 in the tube walls through which access to brain tissue is gained via the channel 36. First and second transmission 37, 38 and deflection means 39, 40 are integrated in the tube walls proximate to the openings at about 15 to 30 mm distance to the catheter tip. The distance D2 of first and second deflection means 39, 40 is about 15 mm resulting in a probing depth of approximately mm. As the tube walls are less than 1 mm thick, preferably about 0,5 mm, the deflection means 39, 40 are realized by cutting the terminating faces of the optical 15 fibers 41 constituting the transmission means 37, 38 with an inclination of approximately 45° with respect to the fiber direction. The inclined face 42 serves as a mirror to deflect light with about 90° from or into the fiber.
V~lith this probe 32 monitoring of parameters by NIRS
techniques can be combined with analytical or therapeutic techniques, for example cerebrospinal fluid analysis and drainage, requiring direct access to deeper brain areas, especially in ventricles.
Fig. 7A, B show an inventive probe 1 with an additional pressure sensor 43. The probe 1 with first and second transmission means 2, 3 and deflection means 6, 7 encapsulated by a soft coating 12 has been described before. A pressure sensor 43 having a signal guide 44 encapsulated by coating 12' is attached to or made in a single piece with the probe 1. For example, as shown in fig. 7A, a standard pressure probe can be equipped with an inventive probe, whereby the respective coatings 12, 12' are attached to each other without forming sharp edges.
Alternatively, as shown in fig. 7B, the pressure sensor is an integral part of the inventive probe, encapsulated by a common coating 12, 12'. The probe thus enables simultaneous monitoring of cerebral hemodynamics and oxygenation as well as pressure through a single probe and a single burr hole in the scull.
Fig. 8 and 9 show different views of an inventive subdural probe 1 with optical probing and a pressure sensor 43 as shown in Fig. 7 inserted through a burr hole 47 in the skull bone 46 between dura 48 and brain tissue 49. As shown, the probe is first guided through a cut 54 in the skin 45, then through the burr hole 47 spaced from the cut 54, thereby minimizing the infection risk by preventing direct contact of brain tissue with the ambient air during long-term monitoring. Zight 30 is deflected by the first deflection means 6 into the brain tissue 49, traveling substantially normal to dura 48 or brain surface where it is absorbed, reflected or scattered. Due to reflection and scattering a part 31 of the light is deviated to the second deflection means 7 and coupled into the second transmission means. The area 55 reached by light emitted by the emitting optode and received by the receiving optode having a distance D is sketched in dashed lines.
The penetration or probing depth P is the maximum depth from where photons are received. V~Tith a distance D of 35 mm the white brain matter can be investigated. The proximal ends 21, 22 of the optical transmission means and of the pressure signal guide terminate in different plugs 50, 51 to be connected with oximetry respectively pressure monitoring systems (not shown).
Fig. 10 shows in its upper part a plan view' and in its lower part a side respectively sectional view of another inventive probe 101 with active generation and detection of light. Light emitting means 102, preferably a diode laser, and light detecting means 106, preferably a receiver diode, are encapsulated by a coating 103, which is preferably made of silicone. The light emitting means 102 are connected via an electrical wiring 104 to an external power supply and/or control unit. The light detecting means 106 are connected via an electrical wiring 105 to an external evaluation system for evaluation of the signals generated by the detecting means 106. The probe 101 is adapted to subdural measurements and has a total length L of about 250 mm, a width W of about 7 mm, and a height T of about 2 mm. The distance D1 between the light emitting and detecting means 102, 106 is about 35 mm.
Claims (23)
1. A probe (1) for cerebral diagnostics or therapy, in particular for measuring characteristics of cerebral hemodynamics and oxygenation by optical reflectance, comprising:
illuminating means comprising first optical transmission means (2) including at least one first optical fiber (4) and first deflection means (6) coupled to the first optical fiber (4) for deflection of transmitted light (30) into a direction other than the direction of light transmission within the first optical fiber (4), the transmitted light (30) for illuminating brain tissue;
light receiving means for receiving light (31) reflected or scattered by the brain tissue, the received light (31) being indicative of cerebral hemodynamics and oxygenation, the light receiving means comprising second optical transmission means (3) including at least one second optical fiber (5) and second deflection means (7) coupled to the second optical fiber (5) for deflection of the light (31) into the second optical fiber (5), the light (31) coming from a direction other than the direction of light transmission within the second optical fiber (5);
wherein the first and second deflection means (6; 7) are located at a distance (DI) from each other of 20 to 50 mm;
a coating encapsulating said illuminating means and said light receiving means, said coating having a longitudinal shape and being adapted to fit through a burr hole in the skull, said coating further being adapted to at least one of the following: sliding between the skull and the dura, being inserted into the ventricular system, being inserted into the cerebral tissue.
illuminating means comprising first optical transmission means (2) including at least one first optical fiber (4) and first deflection means (6) coupled to the first optical fiber (4) for deflection of transmitted light (30) into a direction other than the direction of light transmission within the first optical fiber (4), the transmitted light (30) for illuminating brain tissue;
light receiving means for receiving light (31) reflected or scattered by the brain tissue, the received light (31) being indicative of cerebral hemodynamics and oxygenation, the light receiving means comprising second optical transmission means (3) including at least one second optical fiber (5) and second deflection means (7) coupled to the second optical fiber (5) for deflection of the light (31) into the second optical fiber (5), the light (31) coming from a direction other than the direction of light transmission within the second optical fiber (5);
wherein the first and second deflection means (6; 7) are located at a distance (DI) from each other of 20 to 50 mm;
a coating encapsulating said illuminating means and said light receiving means, said coating having a longitudinal shape and being adapted to fit through a burr hole in the skull, said coating further being adapted to at least one of the following: sliding between the skull and the dura, being inserted into the ventricular system, being inserted into the cerebral tissue.
2. Probe (1) according to claim 1, wherein the first and second deflection means (6 ; 7) are located at a distance (DI) from each other of 30 to 40 mm.
3. Probe (1) according to any one of claims 1 and 2, wherein the coating is made of silicone rubber or polyurethane.
4. Probe (1) according to any one of claims 1-3, having a width (W) less than about 20 mm and a thickness (T) less than about 5 mm.
5. Probe (1) according to any one of claims 1-3, having a width (W) of 5 to 10 mm, and a thickness (T) of less than 2 mm.
6. Probe (1) according to any one of claims 1-5, further comprising a pressure sensor (43) and signal transfer means (44) connected to it for transmitting signals containing pressure information.
7. Probe (1) according to any one of claims 1-6, further comprising means for the transfer and release of a substance into the cerebral tissue or into the ventricular system.
8. Probe (1) according to any one of claims 1 and 2, wherein the first and second deflection means (6 ; 7) deflect light into respectively from a direction (B) substantially vertical to the direction (A) of light propagation in the transmission means (2 ; 3).
9. Probe (1) according to any one of claims 1-8, wherein the first and second deflection means (6 ; 7) include a mirror (10, 11) oriented at approximately 45°
with respect to the direction of the first respectively second optical transmission means (2; 3).
with respect to the direction of the first respectively second optical transmission means (2; 3).
10. Probe (1) according to claim 9, wherein the mirror (10, 11) is a prism (8, 9).
11. Probe (1) according to any one of claims 1-10, wherein the face of the at least one first or second fiber at the distal end of the first respectively second transmission means (2 ; 3) is oriented at approximately 45° with respect to the direction of light propagation (A) within the first respectively second optical transmission means (2; 3).
12. Probe (1) according to any one of claims 1-11, wherein the first and second optical transmission means (2 ; 3) each include a plurality of first respectively second optical fibers (4, 5), the fibers (4, 5) being arranged in a common plane.
13. Probe (1) according to any one of claims 1-12, wherein the coating (12, 12') includes an optical window (13, 14) in the region of the first and second deflection means (6 ; 7).
14. Probe (1) according to any one of claims 1-13, wherein the first and second optical fibers (4, 5) are suited to transmit light within the near infrared region of 700 to 1300 nm spectral range.
15. Probe (1) according to any one of claims 1-13, wherein the first and second optical fibers (4, 5) are suited to transmit light within the near infrared region of 750 to 950 nm.
16. Apparatus for cerebral diagnostics or therapy, in particular for measuring characteristics of cerebral hemodynamics and oxygenation through a burr hole (47) in the skull (46) by optical reflectance, comprising a probe (1) according to any one of claims 1-15, and evaluation means (28) for the evaluation of the detected signals.
17. Apparatus according to claim 16, further comprising light emitting means (24) being coupled with the proximal end (21) of the first transmission means (2, 37), and light detecting means (25) being coupled with the proximal end (22) of the second transmission means (3, 38).
18. Apparatus according to claim 17, wherein the light emitting means (24) include at least one laser emitting in the near infrared region of 700 to 1300 nm spectral range.
19. Apparatus according to claim 17, wherein the light emitting means (24) include at least one diode laser emitting in the near infrared region of 700 to 1300 nm spectral range.
20. Apparatus according to claim 17, wherein the light emitting means (24) include at least one laser emitting in the near infrared region of 750 to 950 nm.
21. Apparatus according to claim 17, wherein the light emitting means (24) include at least one diode laser emitting in the near infrared region of 750 to 950 nm.
22. Apparatus according to any one of claims 17-21, wherein the light emitting means (24) are capable of emitting at three wavelengths.
23. Apparatus according to claim 22, wherein the light emitting means (24) are capable of emitting at about 782 nm, 857 nm and 908 nm.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00115732 | 2000-07-21 | ||
EP00115732.0 | 2000-07-21 | ||
PCT/EP2001/008331 WO2002007592A1 (en) | 2000-07-21 | 2001-07-19 | Probe and apparatus for measuring cerebral hemodynamics and oxygenation |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2416546A1 CA2416546A1 (en) | 2002-01-31 |
CA2416546C true CA2416546C (en) | 2007-12-18 |
Family
ID=8169324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002416546A Expired - Lifetime CA2416546C (en) | 2000-07-21 | 2001-07-19 | Probe and apparatus for measuring cerebral hemodynamics and oxygenation |
Country Status (9)
Country | Link |
---|---|
US (1) | US7120481B2 (en) |
EP (2) | EP1301119B1 (en) |
JP (1) | JP3718500B2 (en) |
AT (1) | ATE297685T1 (en) |
AU (1) | AU2001281996A1 (en) |
CA (1) | CA2416546C (en) |
DE (1) | DE60111531T2 (en) |
ES (1) | ES2242761T3 (en) |
WO (1) | WO2002007592A1 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10315574A1 (en) * | 2003-04-05 | 2004-10-28 | ETH Zürich | Device for determining blood flow in an organ |
EP1547515A1 (en) * | 2003-12-22 | 2005-06-29 | Barts and The London National Health Service Trust | Optical fibre catheter pulse oximeter |
US7570979B2 (en) * | 2004-03-30 | 2009-08-04 | Philip George Cooper | Methods and apparatus for patient monitoring |
JP3721408B2 (en) * | 2004-04-06 | 2005-11-30 | 国立大学法人 岡山大学 | Brain ischemia monitoring monitor |
US7819812B2 (en) | 2004-12-15 | 2010-10-26 | Neuropace, Inc. | Modulation and analysis of cerebral perfusion in epilepsy and other neurological disorders |
US7341562B2 (en) * | 2004-12-15 | 2008-03-11 | Neuropace, Inc. | Modulation and analysis of cerebral perfusion in epilepsy and other neurological disorders |
US9380966B2 (en) | 2007-06-22 | 2016-07-05 | Vioptix, Inc. | Tissue retractor oximeter |
US20090204009A1 (en) * | 2008-02-07 | 2009-08-13 | Los Alamos National Security | Medical device system and related methods for diagnosing abnormal medical conditions based on in-vivo optical properties of tissue |
US8452402B2 (en) * | 2008-04-23 | 2013-05-28 | Medtronic, Inc. | Optical sensing device for use in a medical device |
US9326711B2 (en) * | 2008-06-30 | 2016-05-03 | Medtronic, Inc. | Optical perfusion sensor detector |
US10058274B2 (en) * | 2008-06-30 | 2018-08-28 | Medtronic, Inc. | Tissue perfusion sensor control |
US8086302B2 (en) * | 2008-06-30 | 2011-12-27 | Medtronic, Inc. | Cardiac signal sensor control based on perfusion sensing |
US20100022856A1 (en) * | 2008-07-28 | 2010-01-28 | Medtronic, Inc. | Implantable optical hemodynamic sensor including light transmission member |
US20100022861A1 (en) * | 2008-07-28 | 2010-01-28 | Medtronic, Inc. | Implantable optical hemodynamic sensor including an extension member |
CH699338B1 (en) * | 2008-08-06 | 2012-01-13 | Carag Ag | Device for measuring the blood flow in a body tissue. |
ATE547980T1 (en) | 2008-09-25 | 2012-03-15 | Nemodevices Ag | DEVICE FOR DIAGNOSIS AND/OR THERAPY OF PHYSIOLOGICAL PROPERTIES OF A SELECTED PART OF THE BODY BY OPTICAL REFLECTION OR TRANSMISSION |
KR101034798B1 (en) * | 2009-03-18 | 2011-05-17 | 한국과학기술연구원 | Apparatus for detecting brain conditions |
US9737213B1 (en) * | 2009-03-24 | 2017-08-22 | Vioptix, Inc. | Using an oximeter probe to detect intestinal ischemia |
CH704900A1 (en) | 2011-05-05 | 2012-11-15 | Nemo Devices Ag | Measuring device for measuring cerebral parameters. |
WO2013090658A1 (en) | 2011-12-14 | 2013-06-20 | The Trustees Of The University Of Pennsylvania | Fiber optic flow and oxygenation monitoring using diffuse correlation and reflectance |
US10028682B2 (en) | 2012-10-12 | 2018-07-24 | University Of Virginia Patent Foundation | Oxidation measurement system and related method thereof |
CH707194A1 (en) | 2012-11-06 | 2014-05-15 | Nemodevices Ag | Measuring device for determining cerebral parameters. |
PT2999402T (en) | 2013-05-22 | 2023-03-07 | Luciole Medical AG | Measurement system and method for measuring parameters in a body tissue |
JP6596430B2 (en) * | 2014-01-14 | 2019-10-23 | ザ ジェネラル ホスピタル コーポレイション | Near infrared and diffusion correlation spectroscopy devices and methods |
US10357188B2 (en) * | 2014-10-15 | 2019-07-23 | Koninklijke Philips N.V. | Flexible optical source for pulse oximetry |
US10716499B1 (en) * | 2015-03-24 | 2020-07-21 | Zoll Medical Corporation | Physiological monitoring by optical spectroscopy |
JP6861168B2 (en) | 2015-05-29 | 2021-04-21 | カラク アーゲー | Catheter for measuring blood flow in living tissue |
EP3360464A1 (en) * | 2017-02-10 | 2018-08-15 | Carag AG | Apparatus and method for measuring the blood oxygen saturation in a subject's tissue |
CN108143426A (en) * | 2017-12-26 | 2018-06-12 | 成都拓蓝医疗技术有限公司 | Blood oxygen of brain saturation degree precisely monitors sensor and its monitoring method |
CN112203577A (en) * | 2018-03-01 | 2021-01-08 | 阿齐奥普迪克斯生物医药股份有限公司 | Intracranial imaging and therapy system |
US10973579B2 (en) | 2018-12-28 | 2021-04-13 | Industrial Technology Research Institute | Optical system |
KR102279322B1 (en) * | 2019-04-08 | 2021-07-21 | 한양대학교 산학협력단 | Multimodal diagnostic and therapeutic catheter and catheter system |
DE102019122096A1 (en) | 2019-08-16 | 2021-02-18 | Endress+Hauser Conducta Gmbh+Co. Kg | Optochemical sensor and method |
US11730373B2 (en) * | 2020-04-20 | 2023-08-22 | Covidien Lp | Sensor with variable depth interrogation |
EP4173551A4 (en) | 2020-06-29 | 2023-12-20 | Ant5 Co., Ltd. | Subdural sensor |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281645A (en) | 1977-06-28 | 1981-08-04 | Duke University, Inc. | Method and apparatus for monitoring metabolism in body organs |
EP0119085B1 (en) | 1983-03-10 | 1988-12-07 | Shionogi & Co., Ltd. | Photoelectric brain scanner and its use |
US4784150A (en) * | 1986-11-04 | 1988-11-15 | Research Corporation | Surgical retractor and blood flow monitor |
JPH06103257B2 (en) * | 1988-12-19 | 1994-12-14 | 大塚電子株式会社 | Method and apparatus for measuring absorption coefficient of substance using light scattering |
US5024226A (en) | 1989-08-17 | 1991-06-18 | Critikon, Inc. | Epidural oxygen sensor |
US5193544A (en) | 1991-01-31 | 1993-03-16 | Board Of Trustees Of The Leland Stanford Junior University | System for conveying gases from and to a subject's trachea and for measuring physiological parameters in vivo |
US5218962A (en) | 1991-04-15 | 1993-06-15 | Nellcor Incorporated | Multiple region pulse oximetry probe and oximeter |
US5632273A (en) * | 1994-02-04 | 1997-05-27 | Hamamatsu Photonics K.K. | Method and means for measurement of biochemical components |
US5579774A (en) * | 1994-03-07 | 1996-12-03 | Camino Neurocare, Inc. | Method and apparatus for monitoring local cerebral physiology |
US5685313A (en) | 1994-05-31 | 1997-11-11 | Brain Monitor Ltd. | Tissue monitor |
DE4445683A1 (en) * | 1994-12-21 | 1996-06-27 | Boehringer Mannheim Gmbh | Method for examining a scattering medium with intensity-modulated light |
US5524617A (en) * | 1995-03-14 | 1996-06-11 | Nellcor, Incorporated | Isolated layer pulse oximetry |
US6095974A (en) * | 1995-07-21 | 2000-08-01 | Respironics, Inc. | Disposable fiber optic probe |
JP3426847B2 (en) | 1996-05-14 | 2003-07-14 | アルプス電気株式会社 | Coordinate input device |
US6166806A (en) | 1995-09-29 | 2000-12-26 | Tjin; Swee Chuan | Fiber optic catheter for accurate flow measurements |
GB2333152B (en) | 1998-01-08 | 2002-11-06 | Diametrics Medical Ltd | Method and apparatus for monitoring cerebral physiology |
US6353226B1 (en) * | 1998-11-23 | 2002-03-05 | Abbott Laboratories | Non-invasive sensor capable of determining optical parameters in a sample having multiple layers |
US6615061B1 (en) * | 1998-11-23 | 2003-09-02 | Abbott Laboratories | Optical sensor having a selectable sampling distance for determination of analytes |
US6533733B1 (en) * | 1999-09-24 | 2003-03-18 | Ut-Battelle, Llc | Implantable device for in-vivo intracranial and cerebrospinal fluid pressure monitoring |
-
2001
- 2001-07-19 CA CA002416546A patent/CA2416546C/en not_active Expired - Lifetime
- 2001-07-19 WO PCT/EP2001/008331 patent/WO2002007592A1/en active IP Right Grant
- 2001-07-19 AT AT01960517T patent/ATE297685T1/en not_active IP Right Cessation
- 2001-07-19 DE DE60111531T patent/DE60111531T2/en not_active Expired - Lifetime
- 2001-07-19 ES ES01960517T patent/ES2242761T3/en not_active Expired - Lifetime
- 2001-07-19 JP JP2002513337A patent/JP3718500B2/en not_active Expired - Lifetime
- 2001-07-19 US US10/333,262 patent/US7120481B2/en not_active Expired - Lifetime
- 2001-07-19 EP EP01960517A patent/EP1301119B1/en not_active Expired - Lifetime
- 2001-07-19 AU AU2001281996A patent/AU2001281996A1/en not_active Abandoned
- 2001-07-19 EP EP04105664A patent/EP1504715A1/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CA2416546A1 (en) | 2002-01-31 |
ATE297685T1 (en) | 2005-07-15 |
WO2002007592A1 (en) | 2002-01-31 |
EP1301119B1 (en) | 2005-06-15 |
AU2001281996A1 (en) | 2002-02-05 |
JP3718500B2 (en) | 2005-11-24 |
JP2004504092A (en) | 2004-02-12 |
EP1504715A1 (en) | 2005-02-09 |
DE60111531T2 (en) | 2006-05-11 |
DE60111531D1 (en) | 2005-07-21 |
US20040039270A1 (en) | 2004-02-26 |
EP1301119A1 (en) | 2003-04-16 |
ES2242761T3 (en) | 2005-11-16 |
US7120481B2 (en) | 2006-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2416546C (en) | Probe and apparatus for measuring cerebral hemodynamics and oxygenation | |
US8965472B2 (en) | Method and apparatus for spectrophotometric based oximetry | |
EP0992214B1 (en) | Pulse oximeter and sensor optimized for low saturation | |
US6662033B2 (en) | Pulse oximeter and sensor optimized for low saturation | |
US8428674B2 (en) | Apparatus for spectrometric based oximetry | |
US7130672B2 (en) | Apparatus and method for monitoring tissue vitality parameters | |
US20060161055A1 (en) | Probe design | |
JP2007532188A (en) | Photoplethysmography using spatially uniform multicolor sources | |
US7149562B2 (en) | Needle with fiberoptic capability | |
US20100105998A1 (en) | Method and apparatus for spectrophotometric based oximetry of spinal tissue | |
CA2835004C (en) | Measuring device for measuring cerebral parameters | |
KR20230154434A (en) | Methods and systems for safe injection of dermal filler procedures | |
US20220240858A1 (en) | Apparatus for measuring optical or physiological parameters in scattering media featuring an optical contact detector | |
EP4292524A1 (en) | Intracranial catheter for measuring a flow of blood | |
Gurjar et al. | High reliability, miniature personal hypoxia monitoring system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20210719 |